查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1712618

2025年全球腫瘤栓塞設備市場報告

Tumor Embolization Devices Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10個工作天內

價格
簡介目錄

預計未來幾年腫瘤栓塞裝置的市場規模將強勁成長。到 2029 年，這一數字將成長至 2,2,861 億美元，年複合成長率（CAGR）為 9.3%。預測期內的成長預計將由個人化醫療、聯合治療、影像導引栓塞、遠端醫療和遠距諮詢推動。預測期內的關鍵趨勢包括栓塞劑、經動脈化療栓塞術 (TACE)、安寧療護栓塞術和影像導引手術的創新。

預計預測期內全球癌症發生率的增加將推動腫瘤栓塞設備市場的成長。例如，英國最大的醫療保健慈善機構麥克米倫癌症援助組織在2022年10月預測，到2025年，受癌症影響的人數將達到350萬，到2030年將達到400萬，到2040年將達到530萬。因此，預計全球癌症發生率的上升將在未來幾年推動對腫瘤栓塞裝置的需求。

醫療保健支出的增加將推動腫瘤栓塞設備市場的發展。醫療保健支出包括與提供醫療保健服務相關的所有費用，例如計劃生育、營養計劃和緊急醫療援助。醫療保健支出的增加正在推動各種健康相關產品的發展，包括腫瘤栓塞裝置。例如，根據預算責任辦公室（OBR）和財政部（英國非政府英國公共機構）的經濟預測，英國的醫療衛生支出預計將在2024/25年增至1920億英鎊（2,444.3億美元），而2022/23年則為1,820億英鎊（2,317億美元）。因此，增加醫療保健支出是推動腫瘤栓塞設備市場成長的關鍵因素。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通膨、地緣政治、新冠疫情、經濟復甦對市場的影響

第5章 全球成長分析與策略分析框架

  • 全球腫瘤栓塞設備市場的 PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素、限制因素）
  • 最終用途產業分析
  • 全球腫瘤栓塞設備市場：成長率分析
  • 全球腫瘤栓塞設備市場表現：規模與成長，2019-2024
  • 全球腫瘤栓塞設備市場預測：規模與成長，2024-2029，2034
  • 腫瘤栓塞設備的全球總體目標市場（TAM）

第6章市場區隔

  • 全球腫瘤栓塞設備市場類型、效能及預測（2019-2024、2024-2029、2034）
  • 放射性栓塞劑
  • 非放射性栓塞劑
  • 全球腫瘤栓塞設備市場應用、效能及預測（2019-2024、2024-2029、2034）
  • 癌症腫瘤
  • 非癌性腫瘤
  • 全球腫瘤栓塞設備市場（依最終用戶、績效及預測），2019-2024 年、2024-2029 年、2034 年
  • 醫院
  • 癌症治療中心
  • 加護病房
  • 手術中心
  • 全球腫瘤栓塞設備市場：放射栓塞細分市場（按類型、性能和預測），2019-2024 年、2024-2029 年、2034 年
  • 釔-90（Y-90）微球
  • 钬166微球
  • 全球腫瘤栓塞設備市場：非放射性栓塞劑按類型、性能和預測的細分，2019-2024 年、2024-2029 年、2034 年
  • 藥物釋放型珠（DEB）
  • 微球（聚乙烯醇-PVA顆粒）
  • 明膠海綿
  • 液態栓塞劑（Onyx、黏合劑栓塞劑）

第7章 區域和國家分析

  • 全球腫瘤栓塞設備市場各地區、績效及預測（2019-2024、2024-2029、2034）
  • 全球腫瘤栓塞設備市場：依國家、績效及預測，2019-2024 年、2024-2029 年、2034 年

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章 澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章 德國市場

第18章 法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章競爭格局與公司概況

  • 腫瘤栓塞裝置市場：競爭格局
  • 腫瘤栓塞設備市場：公司簡介
    • Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Sirtex Medical Limited Overview, Products and Services, Strategy and Financial Analysis
    • Merit Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型創新企業

  • Cook Medical LLC
  • AngioDynamics Inc.
  • Siemens Healthineers AG
  • Johnson & Johnson
  • Penumbra Inc.
  • Teleflex Incorporated
  • Meril Life Sciences Pvt. Ltd.
  • Kaneka Corporation
  • Imagion Biosystems Ltd.
  • Guerbet
  • BTI Biotechnology Institute SL
  • BTG International
  • Avinger Inc.
  • Shape Memory Medical Inc.
  • Delcath Systems Inc.

第 32 章全球市場競爭基準化分析與儀表板

第33章 重大併購

第34章近期市場趨勢

第 35 章 高市場潛力國家、細分市場與策略

  • 2029年腫瘤栓塞設備市場：提供新機會的國家
  • 2029年腫瘤栓塞設備市場：細分市場帶來新機會
  • 2029年腫瘤栓塞設備市場：成長策略
    • 基於市場趨勢的策略
    • 競爭對手的策略

第36章 附錄

簡介目錄
Product Code: r32828

Tumor embolization devices are minimally invasive instruments employed in the treatment of tumors. These devices serve the purpose of either occluding the blood supply to the tumor or delivering therapeutic agents directly to the tumor site.

The primary categories of tumor embolization devices include radioembolic agents and non-radioactive embolic agents. Non-radioactive embolic agents encompass materials like gelatin foam, tris-acryl gelatin microspheres, and polyvinyl alcohol (PVA) that are utilized in the treatment of tumors. These applications are relevant to both cancerous and noncancerous tumors, and the devices are employed by various end-users, including hospitals, cancer treatment centers, intensive care units, and surgical centers.

The tumor embolization devices market research report is one of a series of new reports from The Business Research Company that provides tumor embolization devices market statistics, including tumor embolization devices industry global market size, regional shares, competitors with a tumor embolization devices market share, detailed tumor embolization devices market segments, market trends and opportunities, and any further data you may need to thrive in the tumor embolization devices industry. This tumor embolization devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The tumor embolization devices market size has grown strongly in recent years. It will grow from $1493.6 billion in 2024 to $1600.57 billion in 2025 at a compound annual growth rate (CAGR) of 7.2%. The growth in the historic period can be attributed to minimally invasive procedures, technological advancements, cancer incidence, aging population.

The tumor embolization devices market size is expected to see strong growth in the next few years. It will grow to $2286.1 billion in 2029 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to personalized medicine, combination therapies, image-guided embolization, telemedicine and remote consultations. Major trends in the forecast period include innovations in embolic agents, transarterial chemoembolization (tace), embolization for palliative care, image-guided procedures.

The increasing global prevalence of cancer is expected to drive the growth of the tumor embolization devices market during the forecast period. For example, in October 2022, Macmillan Cancer Support, the largest healthcare charity in the UK, projected that the number of cancer cases would reach 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. As a result, the rising cancer incidence worldwide is likely to fuel the demand for tumor embolization devices in the coming years.

The growth in healthcare expenditures is set to drive the tumor embolization devices market. Healthcare expenditures include all costs related to providing healthcare services, such as family planning, nutrition programs, and emergency health assistance. Increased spending in healthcare facilitates the development of various health-related products, including tumor embolization devices. For instance, according to economic forecasts from the Office for Budget Responsibility (OBR) and the Treasury, a UK-based non-departmental public body, the UK's health spending is expected to rise to £192 billion ($244.43 billion) in 2024/25, compared to £182 billion ($231.70 billion) in 2022/23. Thus, the increase in healthcare expenditures is a key factor driving the growth of the tumor embolization devices market.

Key players in the tumor embolization devices market are developing innovative products, such as angiography systems, to improve the accuracy and effectiveness of tumor-targeted treatments. Angiography systems are specialized imaging tools used to visualize blood vessels and evaluate blood flow within the body. For example, in June 2022, Siemens Healthineers, a Germany-based healthcare company, introduced the Artis Icono Ceiling. This ceiling-mounted angiography system is designed to enhance precision in tumor embolization and other interventional procedures. The Artis Icono Ceiling features rapid three-dimensional (3D) data acquisition, capturing images at the patient's head in just 2.5 seconds and from the sides in 4 seconds. This minimizes motion artifacts and reduces the need for contrast media. The system is versatile, making it suitable for various specialties, including interventional radiology and cardiology.

Major companies in the tumor embolization devices market are emphasizing the introduction of innovative treatments, such as Eye90, to maximize market revenue. Eye90 microspheres are a Y90 radioembolization device specifically designed for the treatment of liver tumors, particularly hepatocellular carcinoma. In May 2023, ABK Biomedical, a Canada-based medical device company, obtained Investigational Device Exemption (IDE) approval from the US Food and Drug Administration (FDA) to initiate a multicenter pivotal study of Eye90 microspheres in hepatocellular carcinoma. These microspheres are produced through a proprietary manufacturing process, resulting in uniform size distribution and high radioactivity concentration. They are designed to deliver a high dose of radiation to the tumor while minimizing exposure to healthy tissue.

In August 2022, Boston Scientific, a US-based medical device manufacturer, acquired Obsidio Inc. to strengthen its portfolio in interventional oncology and embolization. Obsidio is a US-based developer of embolization gel.

Major companies operating in the tumor embolization devices market include Boston Scientific Corporation, Medtronic PLC, Terumo Corporation, Sirtex Medical Limited, Merit Medical Systems Inc., Cook Medical LLC, AngioDynamics Inc., Siemens Healthineers AG, Johnson & Johnson, Penumbra Inc., Teleflex Incorporated, Meril Life Sciences Pvt. Ltd., Kaneka Corporation, Imagion Biosystems Ltd., Guerbet, BTI Biotechnology Institute S.L., BTG International, Avinger Inc., Shape Memory Medical Inc., Delcath Systems Inc., Endoshape Inc., InSitu Technologies Inc., Monteris Medical Corporation, NeuWave Medical Inc., Neoprobe Corporation, OncoSec Medical Incorporated, Helomics Corporation, Hologic, Surefire Medical Inc., Varian Medical Systems Inc.

North America was the largest region in the tumor embolization devices market in 2024. Asia-Pacific was the second largest region in the tumor embolization devices market. The regions covered in the tumor embolization devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the tumor embolization devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The tumor embolization devices market consists of sales of radioembolic agents and non-radioactive embolic agents. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Tumor Embolization Devices Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on tumor embolization devices market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for tumor embolization devices ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The tumor embolization devices market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Type: Radioembolic Agents; Non-radioactive Embolic Agents
  • 2) By Application: Cancer Tumors; Noncancerous Tumors
  • 3) By End User: Hospitals; Cancer Treatment Centers; Intensive Care Units; Surgical Centers
  • Subsegments:
  • 1) By Radioembolic Agents: Yttrium-90 (Y-90) Microspheres; Holmium-166 Microspheres
  • 2) By Non-radioactive Embolic Agents: Drug-Eluting Beads (DEBs); Microspheres (Polyvinyl Alcohol - PVA Particles); Gelatin Sponges; Liquid Embolic Agents (Onyx, Glue-Based Agents)
  • Companies Mentioned: Boston Scientific Corporation; Medtronic plc; Terumo Corporation; Sirtex Medical Limited; Merit Medical Systems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Tumor Embolization Devices Market Characteristics

3. Tumor Embolization Devices Market Trends And Strategies

4. Tumor Embolization Devices Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Tumor Embolization Devices Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Tumor Embolization Devices PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Tumor Embolization Devices Market Growth Rate Analysis
  • 5.4. Global Tumor Embolization Devices Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Tumor Embolization Devices Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Tumor Embolization Devices Total Addressable Market (TAM)

6. Tumor Embolization Devices Market Segmentation

  • 6.1. Global Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Radioembolic Agents
  • Non-radioactive Embolic Agents
  • 6.2. Global Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Cancer Tumors
  • Noncancerous Tumors
  • 6.3. Global Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Cancer Treatment Centers
  • Intensive Care Units
  • Surgical Centers
  • 6.4. Global Tumor Embolization Devices Market, Sub-Segmentation Of Radioembolic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Yttrium-90 (Y-90) Microspheres
  • Holmium-166 Microspheres
  • 6.5. Global Tumor Embolization Devices Market, Sub-Segmentation Of Non-radioactive Embolic Agents, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug-Eluting Beads (DEBs)
  • Microspheres (Polyvinyl Alcohol - PVA Particles)
  • Gelatin Sponges
  • Liquid Embolic Agents (Onyx, Glue-Based Agents)

7. Tumor Embolization Devices Market Regional And Country Analysis

  • 7.1. Global Tumor Embolization Devices Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Tumor Embolization Devices Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Tumor Embolization Devices Market

  • 8.1. Asia-Pacific Tumor Embolization Devices Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Tumor Embolization Devices Market

  • 9.1. China Tumor Embolization Devices Market Overview
  • 9.2. China Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Tumor Embolization Devices Market

  • 10.1. India Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Tumor Embolization Devices Market

  • 11.1. Japan Tumor Embolization Devices Market Overview
  • 11.2. Japan Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Tumor Embolization Devices Market

  • 12.1. Australia Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Tumor Embolization Devices Market

  • 13.1. Indonesia Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Tumor Embolization Devices Market

  • 14.1. South Korea Tumor Embolization Devices Market Overview
  • 14.2. South Korea Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Tumor Embolization Devices Market

  • 15.1. Western Europe Tumor Embolization Devices Market Overview
  • 15.2. Western Europe Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Tumor Embolization Devices Market

  • 16.1. UK Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Tumor Embolization Devices Market

  • 17.1. Germany Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Tumor Embolization Devices Market

  • 18.1. France Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Tumor Embolization Devices Market

  • 19.1. Italy Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Tumor Embolization Devices Market

  • 20.1. Spain Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Tumor Embolization Devices Market

  • 21.1. Eastern Europe Tumor Embolization Devices Market Overview
  • 21.2. Eastern Europe Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Tumor Embolization Devices Market

  • 22.1. Russia Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Tumor Embolization Devices Market

  • 23.1. North America Tumor Embolization Devices Market Overview
  • 23.2. North America Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Tumor Embolization Devices Market

  • 24.1. USA Tumor Embolization Devices Market Overview
  • 24.2. USA Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Tumor Embolization Devices Market

  • 25.1. Canada Tumor Embolization Devices Market Overview
  • 25.2. Canada Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Tumor Embolization Devices Market

  • 26.1. South America Tumor Embolization Devices Market Overview
  • 26.2. South America Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Tumor Embolization Devices Market

  • 27.1. Brazil Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Tumor Embolization Devices Market

  • 28.1. Middle East Tumor Embolization Devices Market Overview
  • 28.2. Middle East Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Tumor Embolization Devices Market

  • 29.1. Africa Tumor Embolization Devices Market Overview
  • 29.2. Africa Tumor Embolization Devices Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Tumor Embolization Devices Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Tumor Embolization Devices Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Tumor Embolization Devices Market Competitive Landscape And Company Profiles

  • 30.1. Tumor Embolization Devices Market Competitive Landscape
  • 30.2. Tumor Embolization Devices Market Company Profiles
    • 30.2.1. Boston Scientific Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Medtronic plc Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Terumo Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Sirtex Medical Limited Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Merit Medical Systems Inc. Overview, Products and Services, Strategy and Financial Analysis

31. Tumor Embolization Devices Market Other Major And Innovative Companies

  • 31.1. Cook Medical LLC
  • 31.2. AngioDynamics Inc.
  • 31.3. Siemens Healthineers AG
  • 31.4. Johnson & Johnson
  • 31.5. Penumbra Inc.
  • 31.6. Teleflex Incorporated
  • 31.7. Meril Life Sciences Pvt. Ltd.
  • 31.8. Kaneka Corporation
  • 31.9. Imagion Biosystems Ltd.
  • 31.10. Guerbet
  • 31.11. BTI Biotechnology Institute S.L.
  • 31.12. BTG International
  • 31.13. Avinger Inc.
  • 31.14. Shape Memory Medical Inc.
  • 31.15. Delcath Systems Inc.

32. Global Tumor Embolization Devices Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Tumor Embolization Devices Market

34. Recent Developments In The Tumor Embolization Devices Market

35. Tumor Embolization Devices Market High Potential Countries, Segments and Strategies

  • 35.1 Tumor Embolization Devices Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Tumor Embolization Devices Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Tumor Embolization Devices Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer